Compatibility of Participation Levels of Adolescents With Attention Deficit and Hyperactivity Disorder

Sponsor
Akdeniz University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05407688
Collaborator
(none)
60
3.5

Study Details

Study Description

Brief Summary

The goal of this study is to assess the agreement between the outcomes of adolescents with attention deficit hyperactivity disorder (ADHD) who participated in Participation and Environment Measurement Child & Youth (PEM-CY) by the adolescent and primary caregiver. There are a few studies in the literature that look at the participation of teenagers with ADHD, but none that look at the participation of adolescents with ADHD from both the perspective of the adolescents and the primary caregivers. The primary caregiver's measurement results and the adolescents' measurements do not concur, according to this study's hypothesis.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in childhood. In addition to fundamental symptoms like inattention and hyperactivity/impulsivity, ADHD can be accompanied by a variety of diseases. Adolescents with ADHD are less likely to participate in activities at home, school, or in the community as a result of this. In comparison to children without ADHD, Shimoni et al. found that children with ADHD participate less frequently in most leisure activities, like formal leisure activities less, and have a lower desire for participation in specific leisure activities, such as physical and social leisure activities.

    Adolescents and their primary caregivers have disagreements on a variety of topics. This disagreement is also likely to arise when it comes to choose who will participate. Furthermore, while measuring the level of engagement, the need of gathering information from various sources is clear. The Participation and Environment Measurement-Children and Youth (PEM-CY) is a scale that evaluates parents' or caregivers' involvement with children and young people in the home, school, and community. Adolescents with ADHD had lower levels of participation in the home, school, and community than control groups, according to research. However, no study analyzing this level of bidirectional participation could be found in the existing literature (adolescent-primary caregivers).

    As a result, the primary goal of this study is to examine the participation of adolescents with ADHD from the perspectives of adolescents and primary caregivers using The Participation and Environment Measure for Children and Youth (PEM-CY), as well as to demonstrate the agreement between these two evaluations. Furthermore, it will be compared to healthy controls in terms of participation and agreement rates.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    60 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Compatibility of Participation Levels of Adolescents With Attention Deficit and Hyperactivity Disorder in Terms of Adolescent and Parent Perspectives
    Anticipated Study Start Date :
    Jul 1, 2022
    Anticipated Primary Completion Date :
    Sep 15, 2022
    Anticipated Study Completion Date :
    Oct 15, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    ADHD group

    Adolescents with ADHD

    Health group

    Adolescents without ADHD

    Outcome Measures

    Primary Outcome Measures

    1. Evaluation of participation [baseline]

      Participation and Environment Measurement Child & Youth (PEM-CY) is a parent-report questionnaire to assess participation and environment factors in the home, at school, and within community settings. The participation sections included 10 activities in the home setting, five activities in the school setting and 10 in the community setting. For each activity, parents are asked to determine the participation frequency (how frequently has the child participates with eight options: daily to never), participation involvement (how involved the child is while participating in the activity rated on a five-point scale: very involved to minimally involved) and whether change is desired (do the parents want to see change in the child's participation in this type of activity: no or yes, with five different types of change).

    Secondary Outcome Measures

    1. Evaluation of ADHD symptoms [Baseline]

      The Conners' Ratin Scale - Revised (CRS-R) was designed to address the need for a multimodal assessment of children and adolescents' behavioral difficulties and contains a parent form, a teacher form, and an adolescent self report form. The parent form, the CPRS-R, is appropriate for use with parents of children and adolescents ages 3 through 17. The Long Form contains 80 items and can be completed by most parents/guardians in approximately 20 minutes.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age between 7 years and 12 years;

    • Diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) by a child and adolescent health psychiatrist, regardless of subtype, according to DSM-V criteria

    • Have cognitive ability to follow instructions for assessment measures

    Exclusion Criteria:
    • Children have any other psychiatric diagnosis like autism spectrum disorder, psychotic symptoms, depression, etc.

    • Children have any neurological or orthopedic disorders like head injury, cerebral palsy, epileptic seizure, visual and speech disorder.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Akdeniz University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Ozgun Kaya Kara, Assoc. Prof., Akdeniz University
    ClinicalTrials.gov Identifier:
    NCT05407688
    Other Study ID Numbers:
    • 2021/339
    First Posted:
    Jun 7, 2022
    Last Update Posted:
    Jun 7, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ozgun Kaya Kara, Assoc. Prof., Akdeniz University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 7, 2022